Cipla Ltd India
- J02 - Antimicóticos de uso sistémico
- PHOTERICIN B powder for solution for infusion 50 mg
- L01 - Antineoplásicos
- BLEOCIP powder for solution for injection 15 000 IU(15 mg)
- CYTOBLASTIN solution for injection 10 mg/10 ml
- CYTOCARB concentrate for solution for infusion 150 mg/15 ml
- CYTOCARB concentrate for solution for infusion 450 mg/45 ml
- CYTODRON capsule, hard 500 mg
- CYTOPLATIN concentrate for solution for infusion 10 mg/20 ml
- CYTOPLATIN concentrate for solution for infusion 50 mg/50 ml
- DOCETAX concentrate for solution for infusion 20 mg/0.5 ml
- ETOSID capsule, soft 50 mg
- ETOSID solution for injection 100 mg/5 ml
- IFOS powder for solution for injection 1 000 mg
- IMATIB capsule, hard 100 mg
- METHOCIP solution for injection 50 mg/2 ml
- NEOFLUR concentrate for solution for infusion 250 mg/5 ml
- NEOPHOS powder for solution for injection 1 g
- NEOPHOS powder for solution for injection 200 mg
- ONCODOX powder for solution for injection 10 mg
- ONCODOX powder for solution for injection 50 mg
- PACLITAX concentrate for solution for infusion 30 mg/5 ml
- L02 - Terapia endocrina
- CYTOMID tablet 250 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- SEROFLO inhalation powder, hard capsule 50 µg/dose+100 µg/dose
- SEROFLO inhalation powder, hard capsule 50 µg/dose+250 µg/dose
- SEROFLO inhalation powder, hard capsule 50 µg/dose+500 µg/dose
- V03 - Todos los demás preparados terapéuticos
- KELFER capsule, hard 500 mg
- MESNA solution for injection 100 mg/ml